异动解读|联合利华盘中上涨3.03%,竞购保健品制造商Thorne强化健康业务转型预期

行情直击
Jul 07

7月7日,联合利华盘中上涨3.03%,报63.435美元/股,成交额3903.6万美元。

消息面上,此前市场传出联合利华正评估竞购保健品制造商Thorne的可行性,交易估值最高达40亿美元。Thorne由私募基金L Catterton持有并挂牌出售,另有多家公司也在探讨潜在收购。此举延续了联合利华向健康与个人护理领域聚焦的转型战略——公司已将食品业务剥离予味好美,并于此前完成膳食补充剂品牌Gruns的收购,持续加码高利润率增长赛道。

(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10